Return to Listing

2 result(s) for

PI Name Protocol # Title
Eva Medvedova STUDY00015608 Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Eva Medvedova STUDY00018386 Monoclonal antibody-based sequential therapy for deep remission in multiple myeloma – MASTER trial
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080